SCI Pharmtech Inc is a Taiwan-based company mainly engaged in the research, development, manufacturing, and sales of active pharmaceutical ingredients (APIs), API intermediates, and specialty and precision chemicals. The Company's main product categories are APIs, API intermediates, and specialty chemicals. The Company primarily sells its products in Europe, Asia, the Americas, and other domestic and international markets.

Employees

239

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
21/08/26	NT$52.30	-0.19%	103,660
20/08/26	NT$52.40	+0.77%	85,113
19/08/26	NT$52.00	-0.57%	58,238
18/08/26	NT$52.30	-2.06%	122,979
17/08/26	NT$53.40	+0.75%	426,048

End-of-day quote Taiwan S.E.

More quotes

Annual profits - Rate of surprise

Company calendar

End-of-day quote Taiwan S.E. 21/08/2026			5-day change	1st Jan Change
52.30 ^TWD	-0.19%		-1.32%	+7.39%

08-06	SCI Pharmtech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-07	SCI Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Market Cap	6.25B 196M 168M 157M 144M 270M 18.8B 274M 1.86B 724M 9.42B 737M 721M 31.22B	P/E 2024	20.3x	P/E 2025	54.2x
Enterprise Value	7.16B 225M 192M 180M 165M 309M 21.54B 314M 2.13B 829M 10.8B 845M 827M 35.78B	EV / Sales 2024	7.3x	EV / Sales 2025	5.01x
Free-Float	54.92%	Yield 2024	1.66%	Yield 2025	1.54%

08-06	SCI Pharmtech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-07	SCI Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-05	SCI Pharmtech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-05	SCI Pharmtech, Inc. Proposes Dividend Distribution for the Period from January 1, 2025 to December 31, 2025	CI
11-07	SCI Pharmtech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
06/08/25	SCI Pharmtech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
05/06/25	SCI Pharmtech, Inc. Announces Cash Dividend, Payable on August 5, 2025	CI
26/05/25	SCI Pharmtech, Inc. Announces Changes to its Board, Effective May 26, 2025	CI
08/05/25	SCI Pharmtech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
10/03/25	Sci Pharmtech, Inc. Declares Dividend for Period from January 01, 2024 to December 31, 2024	CI
10/03/25	SCI Pharmtech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
09/01/25	Sci Pharmtech, Inc. Announces Cash Dividend Payment	CI
20/12/24	Sci Pharmtech, Inc. Announces Appointment of Members of the Sustainable Development Committee	CI

29/06/22	SCI Pharmtech : Notice of appointment of general manager of the Board of Directors.	PU
29/06/22	SCI Pharmtech : Notice of the re-election of chairman of the Board of Directors.	PU
21/06/22	SCI Pharmtech : List of the Company's elected directors.	PU
21/06/22	SCI Pharmtech : Notice of the resolutions of 2022 general shareholders' meeting.	PU
21/06/22	SCI Pharmtech : Notice of re-election of functional committees' members	PU

SCI Pharmtech, Inc. Stock

Stocks

4119

TW0004119003

Pharmaceuticals

Valuation: SCI Pharmtech, Inc.

Chart: SCI Pharmtech, Inc.

Latest news : SCI Pharmtech, Inc.

Press Releases: SCI Pharmtech, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: SCI Pharmtech, Inc.

Specialty & Advanced Pharmaceuticals

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

1 day	-0.19%
1 week	-1.32%
Current month	+10.45%
1 month	+8.06%
3 months	+21.49%
6 months	+0.58%
Current year	+7.39%

1 week	51.7	53.8
1 month	47	56.1
Current year	39.6	56.1
1 year	39.6	63.2
3 years	39.6	103
5 years	39.6	119.56
10 years	39.6	119.56

Manager	Title	Age	Since
Wei Chun Weng CEO	Chief Executive Officer	-	-
Wen Chen Yang DFI	Director of Finance/CFO	-	01/01/2003
Wen Chih Chou PRN	Corporate Officer/Principal	-	01/09/2010

Director	Title	Age	Since
Wei Chun Weng CHM	Chairman	-	17/12/2001
Hsiang Li Chen BRD	Director/Board Member	-	17/12/2001
Wen Chih Chou BRD	Director/Board Member	-	01/09/2010

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SCI PHARMTECH, INC.	-0.19%	-1.32%	-11.95%	-47.96%	196M
MERCK & CO., INC.	+2.39%	+12.30%	+77.22%	+39.14%	376B
MERCK KGAA	-0.07%	+1.21%	+24.84%	-12.66%	70.02B
HALOZYME THERAPEUTICS, INC.	+1.93%	+9.64%	+51.05%	+153.80%	12.28B
KYOWA KIRIN CO., LTD.	-1.85%	-0.12%	-2.05%	-0.25%	8.49B
SK BIOPHARMACEUTICALS CO., LTD.	-3.24%	-4.12%	-13.89%	-4.78%	4.73B
YUHAN CORPORATION	-1.32%	-1.67%	-27.62%	+16.94%	4.43B
BETTA PHARMACEUTICALS CO., LTD.	-8.11%	-25.49%	-20.13%	+13.96%	3.2B
SUPERNUS PHARMACEUTICALS, INC.	-3.37%	-5.01%	+5.84%	+46.07%	2.67B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	-2.76%	-3.99%	-14.59%	-6.38%	2.11B
Average	-1.66%	-1.99%	+6.87%	+19.79%	48.45B
Weighted average by Cap.	+1.74%	+9.70%	+64.28%	+32.87%

	2024	2025
Net sales	1.52B 47.89M 40.95M 38.29M 35.05M 65.82M 4.58B 66.8M 453M 176M 2.3B 180M 176M 7.61B	1.34B 42.23M 36.11M 33.76M 30.91M 58.05M 4.04B 58.91M 399M 156M 2.03B 159M 155M 6.71B
Net income	535M 16.8M 14.37M 13.43M 12.3M 23.1M 1.61B 23.44M 159M 61.9M 806M 63.08M 61.71M 2.67B	107M 3.37M 2.89M 2.7M 2.47M 4.64M 323M 4.71M 31.9M 12.43M 162M 12.67M 12.39M 536M
Net Debt	298M 9.35M 8M 7.48M 6.85M 12.86M 895M 13.05M 88.42M 34.46M 449M 35.12M 34.35M 1.49B	912M 28.67M 24.52M 22.93M 20.99M 39.41M 2.74B 40M 271M 106M 1.38B 108M 105M 4.56B